FDA Clears Next SIG Medical AdvantageRib System
Retrieved on:
Thursday, February 14, 2019
HERSHEY, Pa., Feb. 14, 2019 /PRNewswire/ --SIG Medical ( www.sigmedical.net )announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its enhanced AdvantageRib System, K183317.
Key Points:
- HERSHEY, Pa., Feb. 14, 2019 /PRNewswire/ --SIG Medical ( www.sigmedical.net )announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its enhanced AdvantageRib System, K183317.
- This product marks the third rib fracture 510k that SIG Medical is commercializing.
- With this 510k and the product's clinical success to date, SIG Medical plans to make AdvantageRib available nationwide next month.
- SIG Medical has partnered with CWIS in 2019 and plans to conduct hands on training at the meeting in Sante Fe.